Christopher Cline
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Travere Therapeutics, Inc. (TVTX) | Chief Financial Officer | $522,917 | $2,250,914 |
| 2024 | Travere Therapeutics, Inc. (TVTX) | Chief Financial Officer | $497,500 | $1,501,520 |
| 2023 | Travere Therapeutics, Inc. (TVTX) | Chief Financial Officer | $466,667 | $1,971,490 |
| 2022 | Travere Therapeutics, Inc. (TVTX) | Chief Financial Officer | $397,204 | $2,325,646 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.